Training of Inhalation Technique in Hospitalized Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Pilot Study
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | September 28, 2018 | ||
首次发布日期e ICMJE | October 1, 2018 | ||
最后更新发布日期 | October 1, 2018 | ||
预计研究开始日期 ICMJE | October 1, 2018 | ||
预计主要完成日期 | May 15, 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Time to first readmission[ Time Frame: One year after discharge of the last patient ] Time to readmission based on data from the national patient registry |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Training of Inhalation Technique in Hospitalized Patients With Chronic Obstructive Pulmonary Disease (COPD) - a Pilot Study | ||
正式标题 ICMJE | Could Training in Inhalation Technique During the Hospital Stay and Discharge Services From the Pharmacy Reduce the Rate of Readmissions for COPD Patients? - A Pilot Study | ||
简要概况 | Inhalation drugs are essential in the treatment of COPD, in controlling symptoms and preventing exacerbations. The aim of this pilot study is to collect data necessary for the planning of future efficacy trials. We plan to assess the value of providing training in inhalation technique to hospitalized COPD patients. Data on rehospitalizations will be collected from the hospital's medical records and from the National Patient Registry . The inhalation technique of all recruited patients will de assessed at baseline. The patients will then be randomised 1:1 to the intervention or standard care group. The intervention consists of a drug counselling, focusing on inhalation technique. In addition patients in the intervention group will have their medicines personally delivered from the hospital pharmacy at discharge (discharge service). Patients will be asked to fill in questionnaires evaluating the inhalation training and the discharge service |
||
详细说明 | |||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: 盲法: Interventional 盲法描述: 主要目的: Health Services Research |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Recruiting | ||
预计入组 ICMJE |
50 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | May 15, 2020 | ||
预计主要完成日期 | May 15, 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - Patients admitted to the pulmonary ward, the Medical Department, Oslo University Hospital, Oslo, Norway Exclusion Criteria: Patients - previously included to the study - usually not administering their inhalation drugs themselves - using nebulizer chamber with their drug - who are contagious, thus restricting accessibility of personnel - who are not able to provide informed consent | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | Norway | ||
管理信息 | 数据检测委员会 | No | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Liv Mathiesen,Oslo University College | ||
研究赞助商 ICMJE | Oslo University College | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | Oslo University College | ||
验证日期 | September 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |